EXEL
EXELIXIS, INC.
NASDAQ · Healthcare · Biotechnology · US
$70.22
−0.69%Forward multiples
Based on analyst estimates
- P/E forward
- 18.36x
- P/E 2026E
- 18.86x
- P/E 2027E
- 16.71x
- P/E 2028E
- 13.37x
- P/S forward
- 6.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- 20.35x
- PEG TTM
- 1.87x
- Price / book
- 9.34x
- Price / sales
- 6.86x
- Price / cash flow
- 14.61x
Enterprise value
- Enterprise value
- $16.4B
- EV / sales
- 6.57x
- EV / EBITDA
- 15.23x
- EV / EBIT
- 16.35x
- Market cap
- $17.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Oct 1, 2026